# Tamoxifen-MRI Study

> **NCT00295100** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 78 (—)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT00295100
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 78 (—)
- **Last updated:** 2007-06-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295100, "Tamoxifen-MRI Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00295100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*